コンテンツへスキップ
Merck

Use of levonorgestrel intrauterine system for medical indications in adolescents.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine (2013-04-03)
Lisa L Bayer, Paula J Adams Hillard
要旨

The levonorgestrel intrauterine system (LNG-IUS) is an underused contraceptive method in adolescent populations. In addition to being a highly effective, reversible, long-acting contraception, the LNG-IUS has many noncontraceptive health benefits including reduced menstrual bleeding, decreased dysmenorrhea and pelvic pain related to endometriosis, and menstruation suppression in teens with physical or developmental disabilities. The LNG-IUS can also provide endometrial protection in teens with chronic anovulation, and may be used to treat endometrial hyperplasia and cancer. This review examines the evidence supporting the use of the LNG-IUS in adolescents for these noncontraceptive benefits.

材料
製品番号
ブランド
製品内容

USP
レボノルゲストレル, United States Pharmacopeia (USP) Reference Standard
Supelco
D(−)-ノルゲストレル, analytical standard
レボノルゲストレル, European Pharmacopoeia (EP) Reference Standard
システム適合性2用レボノルゲストレル, European Pharmacopoeia (EP) Reference Standard